QT Vascular shareholders vote to reject 5 would-be directors in ongoing board tussle

Annabeth Leow
Published Mon, Dec 6, 2021 · 10:30 PM

SHAREHOLDERS of Catalist-listed QT Vascular 5I0 : 5I0 0% on Monday (Dec 6) rebuffed 5 would-be directors who were up for a vote in an extraordinary general meeting (EGM) in the morning.

The resolutions to appoint Tansri Saridju Benui, Christian Kwok-Leun Yau Heilesen, Stanley Leung Yu Tung, Zhou Jia Lin and Chay Yiowmin to the board were each rejected by shares representing 50.2 per cent of valid votes cast, with 35 valid proxy forms received.

Their failed candidacies are the latest twist after the board of QT Vascular last week raised concerns over the relationships among the proposed directors.

Tansri and shareholder Mission Well had last month requisitioned the EGM to oust then chief executive Eitan Konstantino and 3 other directors from the board of the medtech company.

Konstantino has stepped down, but another EGM on Dec 15 will decide the fates of executive director Momi Mimon Brosh and independent directors Eric Sho Kian Hin and Ng Boon Eng.

Ng, the independent non-executive director who chaired Monday's virtual meeting, said in a bourse filing the company had been told by the requisitioning shareholders that there were no shareholder questions that needed to be addressed regarding the 5 resolutions that later failed.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

QT Vascular called a trading halt on Monday morning "pending the release of announcements".

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here